Re-Innovating Dexmedetomidine (RE03) for the Treatment of stress-induced Insomnia

• Forschungsstelle: INNOSUISSE
• Projektnummer: 119.703 IP-LS
• Projekttitel Englisch: Re-Innovating Dexmedetomidine (RE03) for the Treatment of stress-induced Insomnia

Schlüsselwörter (Englisch)

Life sciences, Pharmaceuticals

Abstract (Englisch)

Insomnia represents a predisposing, perpetuating and precipitating factor in PTSD. Current sleep medications show poor clinical efficacy, leaving an urgent unmet need. Reconnect is committed to develop an innovative sleep medication to break the vicious cycle of hyperarousal-related insomnia in PTSD